Phase Ib, Administration the IOP Injection for MRI Contrast Agent in Healthy Subjects

NCT03399214 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Magnetic Resonance Imaging

Interventions

DRUG: IOP Injection

Sponsor

MegaPro Biomedical Co. Ltd.